Published in Diabetes on August 01, 1985
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia (2012) 10.74
Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes (1970) 6.68
Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia (2005) 4.61
Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care (2001) 4.30
The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18
Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med (1986) 3.90
Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol (1981) 3.30
Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life. J Pediatr (2000) 3.02
Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr (2001) 2.98
Insulinoma: clinical and diagnostic features of 60 consecutive cases. Mayo Clin Proc (1976) 2.93
Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia (2010) 2.91
Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol (1980) 2.75
Liver iron stores in patients with non-insulin-dependent diabetes mellitus. Mayo Clin Proc (1994) 2.71
Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest (1989) 2.69
Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat (2007) 2.58
Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med (1998) 2.58
Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care (1999) 2.53
Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab (1982) 2.45
Exaggerated hyperglycemia after a pizza meal in well-controlled diabetes. Diabetes Care (1993) 2.36
Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med (1987) 2.30
Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest (1997) 2.16
Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab (2000) 2.15
Personal and family factors associated with quality of life in adolescents with diabetes. Diabetes Care (1998) 2.02
Aortoenteric fistula. Incidence, presentation recognition, and management. Ann Surg (1982) 1.97
The role of growth hormone in the development of diabetic retinopathy. Diabetes Care (1994) 1.91
Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes (1988) 1.89
Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med (1979) 1.88
Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care (1999) 1.74
Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. Diabetologia (2007) 1.73
Mechanism and significance of insulin resistance in non-insulin-dependent diabetes mellitus. Diabetes (1981) 1.73
Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest (1980) 1.71
Short-term effects of coping skills training as adjunct to intensive therapy in adolescents. Diabetes Care (1998) 1.63
Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues. J Clin Invest (1986) 1.61
Familial hyperproinsulinemia: partial characterization of circulating proinsulin-like material. Proc Natl Acad Sci U S A (1979) 1.61
Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes (2000) 1.60
Measuring gastric contents during general anaesthesia: evaluation of blind gastric aspiration. Can J Anaesth (1989) 1.60
Use of an automated device for alternative site blood glucose monitoring. Diabetes Care (2001) 1.57
Prospective clinical trial of human growth hormone in short children without growth hormone deficiency. J Pediatr (1984) 1.55
Methods for assessment of the rate of onset and offset of insulin action during nonsteady state in humans. Am J Physiol (1993) 1.52
Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. Brain (1985) 1.51
Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. J Pediatr (1989) 1.51
New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3). Diabetes Obes Metab (2015) 1.47
Direct measurement of brain glucose concentrations in humans by 13C NMR spectroscopy. Proc Natl Acad Sci U S A (1992) 1.46
Clinical and psychosocial factors associated with achievement of treatment goals in adolescents with diabetes mellitus. J Adolesc Health (2001) 1.46
Measurements of glucose control. Diabetes Care (1987) 1.45
Diagnostic interpretation of the intravenous tolbutamide test for insulinoma. Mayo Clin Proc (1989) 1.43
Temporal patterns of circulating leptin levels in lean and obese adolescents: relationships to insulin, growth hormone, and free fatty acids rhythmicity. J Clin Endocrinol Metab (2001) 1.43
67-year-old woman with recurrent hypoglycemia. Mayo Clin Proc (2001) 1.42
Assessment of the postprandial pattern of glucose metabolism in nondiabetic subjects and patients with non-insulin-dependent diabetes mellitus using a simultaneous infusion of [2(3)H] and [3(3)H] glucose. Metabolism (1989) 1.42
Fat distribution and cardiovascular risk factors in obese adolescent girls: importance of the intraabdominal fat depot. Am J Clin Nutr (1996) 1.41
Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes (1990) 1.41
Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes (1982) 1.39
Benign pancreatic insulinoma: preoperative and intraoperative sonographic localization. AJR Am J Roentgenol (1986) 1.37
Long-term improvement of metabolic control with the insulin pump does not reverse diabetic microangiopathy. Diabetes Care (1984) 1.36
Production of insulin resistance by hyperinsulinaemia in man. Diabetologia (1985) 1.36
Continuous subcutaneous infusion of insulin in the management of diabetes mellitus. Diabetes (1980) 1.35
Effects of plasma glucose concentration on glucose utilization and glucose clearance in normal man. Diabetes (1981) 1.35
Systemic and regional free fatty acid metabolism in type 2 diabetes. Am J Physiol Endocrinol Metab (2001) 1.33
Noninsulinoma pancreatogenous hypoglycemia syndrome: an update in 10 surgically treated patients. Surgery (2000) 1.32
Extrapancreatic effects of GIP and GLP-1. Horm Metab Res (2005) 1.32
Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man. Metabolism (1980) 1.28
Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance. J Clin Invest (1996) 1.28
Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy. N Engl J Med (1980) 1.28
Physiological concentrations of growth hormone exert insulin-like and insulin antagonistic effects on both hepatic and extrahepatic tissues in man. J Clin Endocrinol Metab (1981) 1.28
Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy. Diabetes Care (1987) 1.27
Central adiposity and its metabolic correlates in obese adolescent girls. Am J Physiol (1995) 1.26
Effects of changing diagnostic criteria on the risk of developing diabetes. Diabetes Care (1998) 1.25
Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetes. Ann Intern Med (1985) 1.25
Is cimetidine being prescribed indiscriminately? An analytic survey of patients who present with symptoms of peptic ulcer disease. Can Med Assoc J (1984) 1.25
Characteristics of glycemic stability. Diabetes Care (1980) 1.25
Ethnic differences in beta cell adaptation to insulin resistance in obese children and adolescents. Diabetologia (2006) 1.25
Rate of glucose fall does not affect counterregulatory hormone responses to hypoglycemia in normal and diabetic humans. Diabetes (1987) 1.24
Documented hypoglycemia for 23 years in a patient with insulinoma. JAMA (1978) 1.23
Restoration of normal lipid and aminoacid metabolism in diabetic patients treated with a portable insulin-infusion pump. Lancet (1979) 1.23
Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM. Diabetes Care (1998) 1.23
High-fructose feeding elicits insulin resistance, hyperinsulinism, and hypertension in normal mongrel dogs. Hypertension (1994) 1.22
Independent effects of youth and poor diabetes control on responses to hypoglycemia in children. Diabetes (1991) 1.22
Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab (1991) 1.21
Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels. N Engl J Med (1981) 1.21
C-peptide suppression test for insulinoma. J Lab Clin Med (1977) 1.21
Coping skills training for youths with diabetes on intensive therapy. Appl Nurs Res (1999) 1.21
Preoperative detection of pancreatic insulinomas on multiphasic helical CT. AJR Am J Roentgenol (2003) 1.20
Effects of size, time of day and sequence of meal ingestion on carbohydrate tolerance in normal subjects. Diabetologia (1983) 1.20
Impact of a diabetes electronic management system on the care of patients seen in a subspecialty diabetes clinic. Diabetes Care (1998) 1.16
Incretin effect due to increased secretion and decreased clearance of insulin in normal humans. Diabetes (1988) 1.16
Effect of artificial pancreas treatment on peripheral nerve function in diabetes. Neurology (1981) 1.15
Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients. Diabetes (1991) 1.15
Non-response bias in studies of diabetic complications: the Rochester Diabetic Neuropathy Study. J Clin Epidemiol (1993) 1.14
Minimal model assessment of hepatic insulin extraction during an oral test from standard insulin kinetic parameters. Am J Physiol Endocrinol Metab (2009) 1.13
Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus. Gastroenterology (1995) 1.13
Pancreatic duct replication is increased with obesity and type 2 diabetes in humans. Diabetologia (2009) 1.13
Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion. N Engl J Med (1988) 1.12
Prandial insulin requirements in insulin-dependent diabetics: effects of size, time of day, and sequence of meals. J Clin Endocrinol Metab (1983) 1.12